INIT_MET      1      1       Removed.
CHAIN         2    103       Histone H4.
                             /FTId=PRO_0000158320.
DNA_BIND     17     21
MOD_RES       2      2       N-acetylserine.
MOD_RES       2      2       Phosphoserine.
MOD_RES       4      4       Asymmetric dimethylarginine; by PRMT1;
                             alternate.
MOD_RES       4      4       Citrulline; alternate.
MOD_RES       4      4       Omega-N-methylarginine; by PRMT1;
                             alternate.
MOD_RES       4      4       Symmetric dimethylarginine; by PRMT5 and
                             PRMT7; alternate (By similarity).
MOD_RES       6      6       N6-acetyllysine.
MOD_RES       9      9       N6-acetyllysine.
MOD_RES      13     13       N6-acetyllysine.
MOD_RES      17     17       N6-acetyllysine.
MOD_RES      21     21       N6,N6,N6-trimethyllysine; alternate.
MOD_RES      21     21       N6,N6-dimethyllysine; alternate.
MOD_RES      21     21       N6-methyllysine; alternate.
MOD_RES      32     32       N6-acetyllysine.
MOD_RES      48     48       Phosphoserine; by PAK2.
MOD_RES      52     52       Phosphotyrosine.
MOD_RES      60     60       N6-acetyllysine.
MOD_RES      80     80       N6-acetyllysine.
MOD_RES      89     89       Phosphotyrosine.
MOD_RES      92     92       N6-acetyllysine; alternate.
CROSSLNK     92     92       Glycyl lysine isopeptide (Lys-Gly)
                             (interchain with G-Cter in ubiquitin);
                             alternate.
VARIANT      64     64       E -> Q (in a breast cancer sample;
                             somatic mutation).
                             /FTId=VAR_036206.
CONFLICT     71     71       V -> A (in Ref. 14; AAH67496).
CONFLICT     77     77       A -> P (in Ref. 11; CAG46986).
STRAND       21     23
HELIX        27     29
HELIX        32     41
HELIX        51     76
STRAND       80     82
HELIX        84     91
STRAND       98    101
Back to Top